Abstract:The leiomodin (Lmod) family of actin-binding proteins play a critical role in muscle function, highlighted by the fact that mutations in all three family members (LMOD1-3) result in human myopathies. Mutations in the cardiac predominant isoform, LMOD2 lead to severe neonatal dilated cardiomyopathy. Most of the disease-causing mutations in the LMOD gene family are nonsense, or frameshift, mutations predicted to result in expression of truncated proteins. However, in nearly all cases of disease, little to no LMOD protein is expressed. We show here that nonsense-mediated mRNA decay, a cellular mechanism which eliminates mRNAs with premature termination codons, underlies loss of mutant protein from two independent LMOD2 disease-causing mutations. Furthermore, we generated steric-blocking oligonucleotides that obstruct deposition of the exon junction complex, preventing nonsense-mediated mRNA decay of mutant LMOD2 transcripts, thereby restoring mutant protein expression. Our investigation lays the initial groundwork for potential therapeutic intervention in LMOD-linked myopathies. Dilated cardiomyopathy is a common type of heart disease characterized by an enlarged heart that does not contract properly. Dilated cardiomyopathy results from a variety of causes including the presence of an inherited gene mutation. Mutations in the Leiomodin 2 ( LMOD2 ) gene result in a severe form of early-onset dilated cardiomyopathy that, without intervention, leads to death within weeks of birth. The majority of LMOD2 mutations discovered to date are predicted to result in the production of a truncated protein. In all cases thus far analyzed, little to no protein is made. Here we show that a cellular quality control mechanism, referred to as nonsense mediated mRNA decay, is activated to detect and destroy the instructions for making mutant LMOD2 protein, resulting in its loss. Since it was previously shown that at least one mutant LMOD2 protein is functional, we generated a treatment that blocks activation of the quality control mechanism specifically for mutant LMOD2. This treatment results in synthesis of the mutant protein and thus, could have therapeutic potential.

Loss-of-function variants within LMOD1 actin-binding site 2 cause pediatric intestinal pseudo-obstruction by impairing protein stability and actin nucleation

Loss Of Lmod1 Impairs Smooth Muscle Cytocontractility And Causes Megacystis Microcolon Intestinal Hypoperistalsis Syndrome In Humans And Mice

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Human disease-causing mutations result in loss of leiomodin 2 through nonsense-mediated mRNA decay

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Lmod2piggyBac Mutant Mice Exhibit Dilated Cardiomyopathy

Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing

[Analysis of a child with congenital muscular dystrophy due to a novel variant of the LMNA gene]

Compound Heterozygosity for Novel Truncating Variants in the LMOD3 Gene As the Cause of Polyhydramnios in Two Successive Fetuses.

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

A Novel Homozygous Missense Mutation of PIEZO1 Leading to Lymphatic Malformation-6 Identified in a Family with Three Adverse Pregnancy Outcomes Due to Nonimmune Fetal Hydrops.

A lmod1a mutation causes megacystis microcolon intestinal hypoperistalsis in a CRISPR/Cas9-modified zebrafish model

Variants in the Enteric Smooth Muscle Actin Γ-2 Cause Pediatric Intestinal Pseudo-obstruction in Chinese Patients.

Recessive TMOD1 mutation causes childhood cardiomyopathy

LMNA-related Muscular Dystrophy Involving Myoblast Proliferation and Apoptosis Through the FOXO1/GADD45A Pathway.

The Influence of a Genetic Variant in CCDC78 on LMNA-Associated Skeletal Muscle Disease

Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy

A Laing distal myopathy–associated proline substitution in the β-myosin rod perturbs myosin cross-bridging activity

Missense mutation of c.635 T > C in <i>CAPN3</i> impairs muscle injury repair in a Limb-Girdel Muscular Dystropy Model

Lmod2 is necessary for effective skeletal muscle contraction

MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase